Croda International Plc (LON:CRDA - Get Free Report) insider Ian Bull acquired 500 shares of Croda International stock in a transaction that occurred on Friday, August 1st. The shares were purchased at an average cost of GBX 2,643 ($35.31) per share, with a total value of £13,215 ($17,652.95).
Ian Bull also recently made the following trade(s):
- On Tuesday, May 6th, Ian Bull purchased 1,000 shares of Croda International stock. The stock was acquired at an average price of GBX 3,011 ($40.22) per share, with a total value of £30,110 ($40,221.75).
Croda International Stock Performance
Shares of LON:CRDA traded up GBX 13 ($0.17) during trading on Thursday, hitting GBX 2,594 ($34.65). The company's stock had a trading volume of 1,722,807 shares, compared to its average volume of 1,081,636. The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25. Croda International Plc has a 12 month low of GBX 2,527 ($33.76) and a 12 month high of GBX 4,335 ($57.91). The company has a 50-day moving average of GBX 2,940.11 and a 200-day moving average of GBX 3,013.09. The firm has a market cap of £3.63 billion, a price-to-earnings ratio of 22.29, a P/E/G ratio of 1.40 and a beta of 0.74.
Croda International (LON:CRDA - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported GBX 72.20 ($0.96) earnings per share (EPS) for the quarter. Croda International had a net margin of 9.98% and a return on equity of 6.96%. On average, sell-side analysts expect that Croda International Plc will post 181.8307268 earnings per share for the current year.
Wall Street Analysts Forecast Growth
CRDA has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on Croda International from GBX 3,400 ($45.42) to GBX 3,000 ($40.07) and set a "hold" rating on the stock in a research report on Tuesday, July 29th. Berenberg Bank reduced their price objective on Croda International from GBX 3,800 ($50.76) to GBX 3,100 ($41.41) and set a "buy" rating for the company in a research report on Tuesday, July 29th. Citigroup dropped their price target on shares of Croda International from GBX 3,550 ($47.42) to GBX 3,300 ($44.08) and set a "neutral" rating on the stock in a research report on Tuesday, April 29th. Finally, JPMorgan Chase & Co. raised Croda International to an "overweight" rating in a report on Wednesday, July 30th.
View Our Latest Research Report on CRDA
Croda International Company Profile
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
See Also

Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.